Evidence map›Paper›PMID 36542575›Full record

Observational studyRevista medica del Instituto Mexicano del Seguro Social2023

[Hematological indices associated with mortality in critically ill patients with COVID-19].

Aura Angélica López-García, Miguel Ángel Ramos-Choreño, Luis Alejandro Sánchez-Hurtado, Laura Romero-Gutiérrez, Salvador Calleja-Alarcón, Araceli Gudiño-Turrubiates, Natividad Neri-Muñoz, Jesús Manuel Ponce-Sánchez, Tania Colín-Martínez

Abstract readEnglish AbstractObservational Study
In one paragraph

Observational study in Revista medica del Instituto Mexicano del Seguro Social, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Aura Angélica López-GarcíaInstituto Mexicano del Seguro Social, Hospital General de Zona No. 47, Unidad de Cuidados Intensivos. Ciudad de México, México.ORCID 0000-0002-9621-8471
Miguel Ángel Ramos-ChoreñoInstituto Mexicano del Seguro Social, Hospital General de Zona No. 47, Unidad de Cuidados Intensivos. Ciudad de México, México.ORCID 0000-0002-2834-5946
Luis Alejandro Sánchez-HurtadoInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Unidad de Cuidados Intensivos. Ciudad de México, México.ORCID 0000-0001-5662-7679
Laura Romero-GutiérrezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Unidad de Cuidados Intensivos. Ciudad de México, México.ORCID 0000-0002-7756-4416
Salvador Calleja-AlarcónInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Unidad de Cuidados Intensivos. Ciudad de México, México.ORCID 0000-0002-9530-6891
Araceli Gudiño-TurrubiatesInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Unidad de Cuidados Intensivos. Ciudad de México, México.ORCID 0000-0002-3147-4255
Natividad Neri-MuñozInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Dirección Médica. Ciudad de México, México.ORCID 0000-0003-0028-4026
Jesús Manuel Ponce-SánchezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Unidad de Cuidados Intensivos. Ciudad de México, México.ORCID 0000-0002-4197-9425
Tania Colín-MartínezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Admisión Continua. Ciudad de México, México.ORCID 0000-0002-2501-5546

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The COVID-19 disease has represented one of the most important threats to health. The most severe form is acute respiratory distress syndrome (ARDS). The inflammatory response can cause hematologic changes. Objective: To determine the association between the Neutrophil/lymphocyte ratio (NLR) and the mean platelet volume (MPV) associated with mortality in critically ill patients with COVID-19 and ARDS. Material and methods: A retrospective study was carried out in an intensive care unit (ICU) in a public hospital, with patients in critical condition due to COVID-19 and on mechanical ventilation. The clinical characteristics of admission and severity of the disease were recorded. The end point was the ICU discharge condition. Results: 162 subjects were gathered, 103 were men, with a mean age of 54.54 ± 13.53 years. 66.7% died in the ICU. The NLR had an area under the curve (aROC) of 0.62, with a cut-off point for mortality of > 7.04, sensitivity of 94.4%, specificity of 29.63%. The VPM had an aROC of 0.65 with a cut-off point > 9.5, sensitivity of 30.84%, and specificity of 92.59%; finally, the APACHE II had an aROC of 0.67 with a cut-off point > 14, sensitivity of 51.4% and specificity of 80%. The NLR presented an odds ratio (OR) of 5.02, the VPM 2.06 and the APACHE II score 1.16. Conclusions: NLR, MPV, and APACHE II at ICU admission are associated with mortality for critically ill patients with COVID-19.

Indexed as

COVID-19Respiratory Distress SyndromeAdultAgedCritical IllnessFemaleHospital MortalityHumansIntensive Care UnitsMaleMiddle AgedPrognosisRetrospective StudiesCOVID-19Critically IllMean Platelet VolumeMortality

Identifiers

PMID36542575
PMCPMC10395922

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.